A study to evaluate the prevalence and distribution of steatotic and fibrotic liver disease across India
Not Applicable
Completed
- Conditions
- on-alcoholic fatty liver disease (NAFLD)Digestive System
- Registration Number
- ISRCTN18116615
- Lead Sponsor
- Zydus Healthcare Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 13750
Inclusion Criteria
1. Age >18 years
2. Patients who have given consent for the FIBROSCAN™ (VCTE) test
Exclusion Criteria
1. Pregnant or breastfeeding women
2. Individuals with alcohol consumption of more than 30 g and 20 g per day
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of steatotic and fibrotic liver disease measured using Vibration Controlled Transient Elastography (VCTE) parameters, including Controlled Attenuation Parameter (CAP) and Liver Stiffness Measurement (LSM). Data were collected retrospectively from patients who underwent VCTE between January 2023 and April 2024.
- Secondary Outcome Measures
Name Time Method Analysis of age-wise and gender-wise distribution conducted using deidentified patient data. This data was retrospectively collected from January 2023 to April 2024.